Trial record 1 of 3 for:    banking pediatric brain tumor
Previous Study | Return to List | Next Study

Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2012 by National Cancer Institute (NCI)
Sponsor:
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00919750
First received: June 11, 2009
Last updated: November 9, 2012
Last verified: November 2012

June 11, 2009
November 9, 2012
March 2005
Not Provided
  • Collection of brain tumor tissue and an accompanying blood sample from pediatric patients with brain tumors treated at Children's Oncology Group institutions [ Designated as safety issue: No ]
  • Creation of a repository for long-term storage of these specimens [ Designated as safety issue: No ]
  • Making these specimens available to qualified researchers to understand the biology of pediatric brain tumors [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00919750 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens

RATIONALE: Collecting and storing samples of tumor tissue and blood from patients to test in the laboratory may help the study of cancer in the future.

PURPOSE: The purpose of this study is to collect and store brain tissue samples and blood from children with brain cancer that will be tested in the laboratory.

OBJECTIVES:

  • Collect brain tumor tissue and an accompanying blood sample from pediatric patients with brain tumors treated at Children's Oncology Group institutions.
  • Provide a repository for long-term storage of specimens from these patients.
  • Make these specimens available to qualified researchers to understand the biology of pediatric brain tumors.

OUTLINE: This is a multicenter study

Brain tumor tissue and blood specimens are collected from patients and banked for future study.

PROJECTED ACCRUAL: An unlimited number of specimens will be collected.

Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
Brain and Central Nervous System Tumors
Other: biologic sample preservation procedure
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
Not Provided
Not Provided

DISEASE CHARACTERISTICS:

  • Diagnosis of brain tumor
  • Previously treated at a Children's Oncology Group (COG) institution

    • Patients are eligible at time of diagnosis, second-look surgery, recurrence, or development of a second malignant neoplasm
  • Must have brain tumor biological specimens derived from primary tumors of the CNS available for submission

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified
Both
up to 18 Years
No
United States,   Australia,   Canada,   New Zealand,   Puerto Rico,   Switzerland
 
NCT00919750
CDR0000352347, COG-ACNS02B3
Not Provided
Not Provided
Children's Oncology Group
National Cancer Institute (NCI)
Study Chair: Scott Pomeroy, MD Children's Hospital Boston
Investigator: Jaclyn A. Biegel, PhD Children's Hospital of Philadelphia
National Cancer Institute (NCI)
November 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP